Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Dragonfly Therapeutics
AstraZeneca
Genmab
Seagen Inc.
Seagen Inc.
Fondazione del Piemonte per l'Oncologia
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Emory University
Hoffmann-La Roche
M.D. Anderson Cancer Center
Ankyra Therapeutics, Inc
Deciphera Pharmaceuticals, LLC
STORM Therapeutics LTD
Peking University Cancer Hospital & Institute
Pfizer
Neonc Technologies, Inc.
Hummingbird Bioscience
Erasca, Inc.
University of Cincinnati
Bristol-Myers Squibb
Bayer
Pfizer
Radiopharm Theranostics, Ltd
Pfizer
Arvinas Inc.
Boehringer Ingelheim
Aulos Bioscience, Inc.
Essen Biotech
Replimune Inc.
Shanghai Henlius Biotech
OHSU Knight Cancer Institute
Wake Forest University Health Sciences
University of Oklahoma
Werewolf Therapeutics, Inc.
MacroGenics
DualityBio Inc.
MacroGenics
Novartis
Pfizer
University of California, Davis